BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33159025)

  • 1. TGF-β1-regulated miR-3691-3p targets
    Hu YM; Lou XL; Liu BZ; Sun L; Wan S; Wu L; Zhao X; Zhou Q; Sun MM; Tao K; Zhang YS; Wang SL
    Asian J Androl; 2021; 23(2):188-196. PubMed ID: 33159025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA MiR-130a-3p promotes gastric cancer by targeting Glucosaminyl N-acetyl transferase 4 (GCNT4) to regulate the TGF-β1/SMAD3 pathway.
    Hu W; Zheng X; Liu J; Zhang M; Liang Y; Song M
    Bioengineered; 2021 Dec; 12(2):11634-11647. PubMed ID: 34696660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA NEAT1 facilitates melanoma cell proliferation, migration, and invasion via regulating miR-495-3p and E2F3.
    Xia Y; Zhou Y; Han H; Li P; Wei W; Lin N
    J Cell Physiol; 2019 Nov; 234(11):19592-19601. PubMed ID: 31173352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brevilin A shows an anti-tumor role in prostate cancer via the lncRNA H19/miR-194/E2F3 signaling pathway.
    You P; Tang L; Zhu Y; Tian Y
    Aging (Albany NY); 2023 May; 15(10):4411-4428. PubMed ID: 37253635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
    Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
    Zhang D; Yang XJ; Luo QD; Xue L; Chong T
    Cancer Gene Ther; 2022 Jul; 29(7):1001-1011. PubMed ID: 34799723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-4638-3p regulates transforming growth factor-β1-induced activating transcription factor-3 and cell proliferation, invasion, and apoptosis in human breast cancer cells.
    Akshaya RL; Rohini M; He Z; Partridge NC; Selvamurugan N
    Int J Biol Macromol; 2022 Dec; 222(Pt B):1974-1982. PubMed ID: 36208811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-210-3p enhances intermittent hypoxia-induced tumor progression via inhibition of E2F3.
    Zhang XB; Song Y; Lai YT; Qiu SZ; Hu AK; Li DX; Zheng NS; Zeng HQ; Lin QC
    Sleep Breath; 2024 May; 28(2):607-617. PubMed ID: 37775619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown SNHG20 Suppresses Nonsmall Cell Lung Cancer Development by Repressing Proliferation, Migration and Invasion, and Inducing Apoptosis by Regulating miR-2467-3p/E2F3.
    Chen H; Tan X; Ding Y
    Cancer Biother Radiopharm; 2021 May; 36(4):360-370. PubMed ID: 32456448
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study.
    Nalla LV; Gondaliya P; Kalia K; Khairnar A
    Mol Biol Rep; 2022 Jul; 49(7):6987-6996. PubMed ID: 35486287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF4A3-induced circWAC promotes breast cancer progression through mediating miR-599/E2F3 axis.
    Huang WH; Yang Q; Zhang C
    Kaohsiung J Med Sci; 2022 Apr; 38(4):321-335. PubMed ID: 34989110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circANKS1B acts as a sponge for miR-152-3p and promotes prostate cancer progression by upregulating TGF-α expression.
    Tao LJ; Pan XY; Wang JW; Zhang L; Tao LS; Liang CZ
    Prostate; 2021 Apr; 81(5):271-278. PubMed ID: 33556191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
    J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0008934 promotes the proliferation and migration of osteosarcoma cells by targeting miR-145-5p to enhance E2F3 expression.
    Li S; Zeng M; Yang L; Tan J; Yang J; Guan H; Kuang M; Li J
    Int J Biochem Cell Biol; 2020 Oct; 127():105826. PubMed ID: 32822848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
    Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3.
    Park MC; Kim H; Choi H; Chang MS; Lee SK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.